In short, they most likely bounce from this level for a short time, but whether they continue their bull run or not depends on price action in the next couple weeks. I have some remarks on the charts that might help following up with their moves. The RSI for all three companies are in oversold area and historically we have seen them move back up when they hit 30...
Looks like a head and shoulders top and the neckline was broken a while back. Bad news about the vaccine caused a gap down. Appears NVAX has hit the 100% down target for the ugly top, but does not always mean it is over as it can be an extension as well.
Sometimes looking at a candle that forms on the day of the gap down can help. This one made large gains at...
Hopefully you find the chart helpful in terms of Supports & Resistance etc.
we refrain from adding commentary on the chart as that is reserved for our members and we are very conscious of not giving financial or trading advice.
Thank you for taking time to consult our chart and we would really appreciate a like, follow or comment.
This is a Part 2 from what I posted earlier. I posted a bear thesis of NVAX first. Nvax has downside to $30 or upside beyond $700 if it can get past the barriers it has up. It needs news to move it.
I am using historical patterns to predict the future for this stock. There are reasons to think this stock will be bullish, however, historical analysis shows that NVAX might be nearing its end. I am only pointing to direction here and not using fib levels in order to make the chart as easy as possible to follow
NVAX jumped roughly 20% overnight after announcing 96.4% efficacy against the disease caused by the original COVID-19 strain. This single move caused the shares to break out from the downside channel and crack through the 50-day and 20-day moving averages. With this important resistance zone left behind, the shares are poised to open just above the yearly...
The charts dont lie. Vaccine company do. This company is not even worth $10. Earnings in 9 days they will have to report that the company cannot produce and wasnt intending on every producing.
Novavax will issue a statement ahead of their upcoming earnings in a couple of weeks that they have scrapped the plans for a Covid-19 vaccine and now instead they are working on a Covid-flu combo for the next year . The insiders and the main hedge fund manager Peter Kolchinsky have already shorted the stock last week . I fully expect It will be anywhere between...
The truth about Novavax is that execs like Stanley Erck , Gregory Glenn , John Trizzino and John Hermann are taking orders from financial institutions like Blackrock , Vanguard , RA Capital... they short & go long NVAX along with them through their family members/friends . There is more money for them in these stock fluctuations than getting the vaccine FINALLY to...
If NVAX opens higher than 166 and keep moving up during the session today, we could see a validation of a Morning star bullish pattern which mean a bullish reversal.
No products and data manipulation comes to halt with earnings reports soon will have to give data of production halts.
Data manipulation artificially inflated prices for insiders to dump shares recently. Pump and dump.
Novavax, Inc. focuses on the discovery, development and commercialization of vaccines to prevent infectious diseases. It provides vaccines for COVID-19, seasonal flu, respiratory syncytial virus, Ebola, and Middle East respiratory syndrome. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
NASDAQ
